Clinical trial
Hemodynamic-GUIDEd Management of Heart Failure
NCT03387813
Study timeline
Study start (actual)2018-03-15Date precision: day
Registry last updated2025-08-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureverified · MONDO: heart failure
Heart Failure NYHA Class IIunresolved
Heart Failure NYHA Class IIIunresolved
Heart Failure NYHA Class IVunresolved
Heart Failure; With Decompensationunresolved
Interventions
CardioMEMS™ HF SystemDEVICE
Sponsors & collaborators
Abbott Medical Deviceslead sponsor
Mapped research locations
HoustonTexas, United States4New YorkNew York, United States3PhoenixArizona, United States3Los AngelesCalifornia, United States2PhiladelphiaPennsylvania, United States2NashvilleTennessee, United States2SeattleWashington, United States2ClevelandOhio, United States2ColumbusOhio, United States2MinneapolisMinnesota, United States2JacksonvilleFlorida, United States2Oklahoma CityOklahoma, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03387813 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.